Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Zager

Showing results (161-170 of 247) with videos related to

Pageof 25
Sort By:
Journal of the American College of Surgeons|April 6, 2011
Shave biopsy is a safe and accurate method for the initial evaluation of melanomaJonathan S Zager, Steven N Hochwald, Suroosh S Marzban, et al.
Annals of Surgical Oncology|March 10, 2016
Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?Matthew P Doepker, Zachary J Thompson, Kate J Fisher, et al.
Melanoma Management|September 8, 2018
Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experienceDaniel E Oliver, Vernon K Sondak, Tobin Strom, et al.
Melanoma Management|August 22, 2020
Observational study of talimogene laherparepvec use in the anti-PD-1 era for melanoma in the US (COSMUS-2)James Sun, Brian R Gastman, Lucy McCahon, et al.
Annals of Surgical Oncology|June 23, 2009
Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysisAlfredo A Santillan, Keith A Delman, Georgia M Beasley, et al.
Journal of Surgical Oncology|March 19, 2019
Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefitNicholas D Klemen, Gang Han, Stanley P Leong, et al.
Annals of Surgical Oncology|March 11, 2025
Identification of Predictive Factors for the Development of In-Transit Metastasis in Patients with MelanomaAnne Huibers, Stanley P Leong, Mohammed Kashani-Sabet, et al.
Melanoma Research|January 6, 2016
BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategySarah Sloot, Jonathan S Zager, Ragini R Kudchadkar, et al.
Journal of Surgical Oncology|September 18, 2021
Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence-free survivalSarayu Subramanian, Gang Han, Natalie Olson, et al.
Surgery|June 14, 2021
Regression is significantly associated with outcomes for patients with melanomaSarayu Subramanian, Gang Han, Natalie Olson, et al.
Pageof 25

Showing results (161-170 of 247) with videos related to

Sort By:
Pageof 25
Journal of the American College of Surgeons|April 6, 2011
Shave biopsy is a safe and accurate method for the initial evaluation of melanomaJonathan S Zager, Steven N Hochwald, Suroosh S Marzban, et al.
Annals of Surgical Oncology|March 10, 2016
Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?Matthew P Doepker, Zachary J Thompson, Kate J Fisher, et al.
Melanoma Management|September 8, 2018
Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experienceDaniel E Oliver, Vernon K Sondak, Tobin Strom, et al.
Melanoma Management|August 22, 2020
Observational study of talimogene laherparepvec use in the anti-PD-1 era for melanoma in the US (COSMUS-2)James Sun, Brian R Gastman, Lucy McCahon, et al.
Annals of Surgical Oncology|June 23, 2009
Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysisAlfredo A Santillan, Keith A Delman, Georgia M Beasley, et al.
Journal of Surgical Oncology|March 19, 2019
Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefitNicholas D Klemen, Gang Han, Stanley P Leong, et al.
Annals of Surgical Oncology|March 11, 2025
Identification of Predictive Factors for the Development of In-Transit Metastasis in Patients with MelanomaAnne Huibers, Stanley P Leong, Mohammed Kashani-Sabet, et al.
Melanoma Research|January 6, 2016
BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategySarah Sloot, Jonathan S Zager, Ragini R Kudchadkar, et al.
Journal of Surgical Oncology|September 18, 2021
Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence-free survivalSarayu Subramanian, Gang Han, Natalie Olson, et al.
Surgery|June 14, 2021
Regression is significantly associated with outcomes for patients with melanomaSarayu Subramanian, Gang Han, Natalie Olson, et al.
Pageof 25